Goldman Sachs’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.07M Sell
70,000
-32,700
-32% -$3.13M ﹤0.01% 3509
2025
Q4
$9.87M Buy
102,700
+88,000
+599% +$8.55M ﹤0.01% 3108
2025
Q3
$1.4M Sell
14,700
-79,600
-84% -$7.32M ﹤0.01% 4792
2025
Q2
$8.22M Sell
94,300
-23,400
-20% -$1.98M ﹤0.01% 2939
2025
Q1
$10.6M Buy
117,700
+95,100
+421% +$8.51M ﹤0.01% 2643
2024
Q4
$1.81M Hold
22,600
﹤0.01% 4371
2024
Q3
$2.03M Hold
22,600
﹤0.01% 4140
2024
Q2
$1.78M Buy
22,600
+2,600
+13% +$213K ﹤0.01% 4011
2024
Q1
$1.74M Buy
20,000
+15,800
+376% +$1.35M ﹤0.01% 3960
2023
Q4
$346K Buy
+4,200
New +$320K ﹤0.01% 4925
2023
Q2
Sell
-340,000
Closed -$27.4M 5944
2023
Q1
$27.4M Buy
340,000
+76,600
+29% +$6.24M 0.01% 1529
2022
Q4
$20.5M Buy
263,400
+237,400
+913% +$19.2M 0.01% 1935
2022
Q3
$2.1M Buy
26,000
+13,400
+106% +$1.2M ﹤0.01% 3929
2022
Q2
$1.13M Sell
12,600
-121,500
-91% -$12.3M ﹤0.01% 4517
2022
Q1
$14.9M Sell
134,100
-68,200
-34% -$7.21M ﹤0.01% 2302
2021
Q4
$20.9M Buy
202,300
+30,400
+18% +$3.52M ﹤0.01% 2074
2021
Q3
$21.5M Buy
171,900
+89,500
+109% +$11.6M ﹤0.01% 2002
2021
Q2
$10.2M Sell
82,400
-8,500
-9% -$1.07M ﹤0.01% 2668
2021
Q1
$10.7M Sell
90,900
-145,700
-62% -$17.1M ﹤0.01% 2502
2020
Q4
$27.7M Buy
236,600
+113,600
+92% +$12.5M 0.01% 1582
2020
Q3
$12.8M Buy
123,000
+62,300
+103% +$6.26M ﹤0.01% 2102
2020
Q2
$5.57M Sell
60,700
-173,100
-74% -$16.6M ﹤0.01% 2719
2020
Q1
$21.1M Buy
233,800
+90,900
+64% +$9.67M 0.01% 1467
2019
Q4
$16.2M Buy
142,900
+600
+0.4% +$65.8K ﹤0.01% 2039
2019
Q3
$15.5M Sell
142,300
-159,700
-53% -$16.7M ﹤0.01% 1989
2019
Q2
$29.4M Buy
302,000
+165,500
+121% +$15.1M 0.01% 1555
2019
Q1
$12.4M Sell
136,500
-36,600
-21% -$3.28M ﹤0.01% 2244
2018
Q4
$15.7M Buy
173,100
+30,500
+21% +$2.85M 0.01% 1994
2018
Q3
$14M Sell
142,600
-33,900
-19% -$3.13M ﹤0.01% 2191
2018
Q2
$15.1M Sell
176,500
-41,900
-19% -$3.5M ﹤0.01% 2101
2018
Q1
$17.5M Buy
218,400
+80,200
+58% +$6.62M ﹤0.01% 1950
2017
Q4
$11.2M Sell
138,200
-42,200
-23% -$3.38M ﹤0.01% 2382
2017
Q3
$14M Sell
180,400
-7,200
-4% -$598K ﹤0.01% 2274
2017
Q2
$16.6M Buy
187,600
+89,500
+91% +$7.55M ﹤0.01% 2086
2017
Q1
$7.9M Sell
98,100
-330,005
-77% -$25.8M ﹤0.01% 2566
2016
Q4
$30.5M Sell
428,105
-104,755
-20% -$8.23M 0.01% 1641
2016
Q3
$46M Sell
532,860
-326,200
-38% -$28.4M 0.01% 1269
2016
Q2
$74.5M Buy
859,060
+75,000
+10% +$6.07M 0.02% 844
2016
Q1
$58.8M Buy
784,060
+458,180
+141% +$34.5M 0.02% 976
2015
Q4
$25.1M Sell
325,880
-645,190
-66% -$48.6M 0.01% 1587
2015
Q3
$65M Buy
971,070
+356,745
+58% +$26.3M 0.02% 873
2015
Q2
$45.5M Sell
614,325
-30,810
-5% -$2.35M 0.01% 1184
2015
Q1
$50.3M Buy
645,135
+354,635
+122% +$26.9M 0.02% 1097
2014
Q4
$21M Buy
290,500
+31,000
+12% +$2.15M 0.01% 1789
2014
Q3
$16.1M Buy
259,500
+8,400
+3% +$534K 0.01% 1967
2014
Q2
$16M Sell
251,100
-155,200
-38% -$9.43M 0.01% 1974
2014
Q1
$25M Sell
406,300
-253,700
-38% -$14.8M 0.01% 1583
2013
Q4
$37.9M Buy
660,000
+185,200
+39% +$10.5M 0.01% 1257
2013
Q3
$25.3M Sell
474,800
-127,400
-21% -$6.86M 0.01% 1426
2013
Q2
$31M Buy
+602,200
New +$29.8M 0.01% 1214

Other funds holding MDT

Goldman Sachs's MDT Position: Q1 2026 in Review

Goldman Sachs reduced its Medtronic (MDT) stake by 4.6% in Q1 2026, selling an estimated $25.9M and leaving 5,600,590 shares worth $485M. The position accounts for 0.06% of the portfolio, ranked #357.

Goldman Sachs first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Goldman Sachs held 5,600,590 shares of Medtronic worth $485M as of Q1 2026.
  • Goldman Sachs sold 270,158 Medtronic shares in Q1 2026, an estimated $25.9M.
  • Medtronic made up 0.06% of Goldman Sachs's portfolio in Q1 2026, its #357 holding.
  • Goldman Sachs first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Medtronic position peaked at $1.54B in Q2 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.